Sort
10,766 grants matching “checkpoint inhibitor”
Quantitative PET Imaging for Oncologic Immune Response Prediction
$247,942Benjamin M Larimer · University Of Alabama At Birmingham · R00 · FY2019 · CA
G2 Checkpoint Function in Human Fibroblasts
$247,885William K Kaufmann · Univ Of North Carolina Chapel Hill · R01 · FY2006 · CA
Combinatorial Approaches to Overcoming Resistance to BRAF(V600E) Targeted Thera
$247,819David E Fisher · Massachusetts General Hospital · P01 · FY2017 · CA
Project 3 - Novel Therapies for Spliceosomal-Mutant MDS.
$247,646Matthew J Walter · Washington University · P50 · FY2023 · CA
Role of Acid in the Development of Barrett's Esophagus
$247,590Rhonda F Souza · Ut Southwestern Medical Center · R01 · FY2009 · DK
Core 3: Mouse GBM models and Imaging Core
$247,517E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2023 · CA
Core 3: Mouse GBM models and Imaging Core
$247,517E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2022 · CA
Mechanisms of improved organ function following sepsis treatment with vitamin c, thiamine and hydrocortisone (triple therapy)
$247,500Daniel G. Remick · Boston University Medical Campus · R21 · FY2020 · AI
Targeting the host NDP kinase to abrogate viral dissemination
$247,500Chengyu Liang · University Of Southern California · R21 · FY2019 · DE
Endogenous and Environmental AHR Ligands in Head and Neck Cancer Aggression and Immunosuppression
$247,500David H Sherr · Boston University Medical Campus · R21 · FY2019 · ES
Core 3: Mouse GBM models and Imaging Core
$247,440E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2020 · CA
Targeting JAB1 Oncogenic Function in Breast Cancer
$247,358Francois X Claret · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Utilizing MEK Inhibition to Sensitize Microsatellite Stable Colorectal Cancer to Immune Checkpoint Therapy
$247,340Christopher Hanyoung Lieu · University Of Colorado Denver · R01 · FY2018 · CA
Regulation of the Anaphase-Promoting Complex
$247,340University Of Texas Sw Med Ctr/Dallas · R01 · FY2001 · GM
A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR
$247,249Sean S Park · Mayo Clinic Rochester · R01 · FY2017 · CA
A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR
$247,249Sean S Park · Mayo Clinic Rochester · R01 · FY2016 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$247,218Fernando Macian · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · CA
Research Project Cervical Cancer
$247,065Julie Kristina Schwarz · Washington University · U54 · FY2024 · CA
Inter-regulatory function of immune-modulation and angiogenesis in cancer
$247,046Gabriele Bergers · Flanders Interuniv Inst Biotechnology · R01 · FY2020 · CA
Inducing Tumor Neoantigens Through RNA Editing for Cancer Immunotherapy
$246,711Jeffrey A. Hubbell · University Of Chicago · R21 · FY2023 · CA
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma
$246,498Nicole Schmitt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2020 · DC
Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer
$246,369Christopher J. Halbrook · University Of California-Irvine · R00 · FY2022 · CA
Project 3
$246,163Michelle Krogsgaard · New York University School Of Medicine · P50 · FY2023 · CA
Project 3: HHLA2 as a THerapeutic Target in RCC
$246,071David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2022 · CA
An Engineered CRISPR System for Boosting Tumor Immunogenicity.
$246,000Weixin Tang · University Of Chicago · R21 · FY2022 · EB